189 related articles for article (PubMed ID: 29412385)
1. Serum selenium and selenoprotein-P levels in autoimmune thyroid diseases patients in a select center: a transversal study.
Federige MAF; Romaldini JH; Miklos ABPP; Koike MK; Takei K; Portes ES
Arch Endocrinol Metab; 2017 Dec; 61(6):600-607. PubMed ID: 29412385
[TBL] [Abstract][Full Text] [Related]
2. Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto's thyroiditis and hypothyroidism.
Nourbakhsh M; Ahmadpour F; Chahardoli B; Malekpour-Dehkordi Z; Nourbakhsh M; Hosseini-Fard SR; Doustimotlagh A; Golestani A; Razzaghy-Azar M
J Trace Elem Med Biol; 2016 Mar; 34():10-4. PubMed ID: 26854239
[TBL] [Abstract][Full Text] [Related]
3. A Prospective Study to Evaluate the Possible Role of Cholecalciferol Supplementation on Autoimmunity in Hashimoto's Thyroiditis.
Bhakat B; Pal J; Das S; Charaborty SK; SircarMedical NR; Kolkata ; RGKar ; NorthBengal ; Siliguri
J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116030
[TBL] [Abstract][Full Text] [Related]
4. Altered expression profile of BAFF receptors on peripheral blood B lymphocytes in Graves' disease.
Wang X; Huang J; Zhang A; Fang C; Ma Q; Jiang P
BMC Endocr Disord; 2021 Apr; 21(1):88. PubMed ID: 33926416
[TBL] [Abstract][Full Text] [Related]
5. 25-Hydroxyvitamin D serum level in Hashimoto's thyroiditis, but not Graves' disease is relatively deficient.
Ke W; Sun T; Zhang Y; He L; Wu Q; Liu J; Zha B
Endocr J; 2017 Jun; 64(6):581-587. PubMed ID: 28413173
[TBL] [Abstract][Full Text] [Related]
6. Serum selenium is low in newly diagnosed Graves' disease: a population-based study.
Bülow Pedersen I; Knudsen N; Carlé A; Schomburg L; Köhrle J; Jørgensen T; Rasmussen LB; Ovesen L; Laurberg P
Clin Endocrinol (Oxf); 2013 Oct; 79(4):584-90. PubMed ID: 23448365
[TBL] [Abstract][Full Text] [Related]
7. Lower Serum 25-Hydroxyvitamin D Level is Associated With 3 Types of Autoimmune Thyroid Diseases.
Ma J; Wu D; Li C; Fan C; Chao N; Liu J; Li Y; Wang R; Miao W; Guan H; Shan Z; Teng W
Medicine (Baltimore); 2015 Sep; 94(39):e1639. PubMed ID: 26426654
[TBL] [Abstract][Full Text] [Related]
8. Serum selenium status in Graves' disease and Hashimoto's thyroiditis in an iodine-sufficient area: A case-control study.
Heidari Z; Sheikhi V
J Res Med Sci; 2022; 27():87. PubMed ID: 36685028
[TBL] [Abstract][Full Text] [Related]
9. Assessment of serum dipeptidyl peptidase-IV levels in autoimmune thyroid disease.
Zhang Y; Fu Y; Yang Y; Ke J; Zhao D
J Int Med Res; 2022 Jul; 50(7):3000605221112031. PubMed ID: 35903860
[TBL] [Abstract][Full Text] [Related]
10. Low serum interleukin-38 levels in patients with Graves' disease and Hashimoto's thyroiditis.
Xu J; Huang G; Weng L; Gong L; Mao Y; Li Y; Li M
J Clin Lab Anal; 2022 Jan; 36(1):e24101. PubMed ID: 34799942
[TBL] [Abstract][Full Text] [Related]
11. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
[TBL] [Abstract][Full Text] [Related]
12. Serum selenium status in Graves' disease with and without orbitopathy: a case-control study.
Khong JJ; Goldstein RF; Sanders KM; Schneider H; Pope J; Burdon KP; Craig JE; Ebeling PR
Clin Endocrinol (Oxf); 2014 Jun; 80(6):905-10. PubMed ID: 24372054
[TBL] [Abstract][Full Text] [Related]
13. Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy.
Marinò M; Rotondo Dottore G; Ionni I; Lanzolla G; Sabini E; Ricci D; Sframeli A; Mazzi B; Menconi F; Latrofa F; Vitti P; Marcocci C; Chiovato L
J Endocrinol Invest; 2019 Apr; 42(4):471-480. PubMed ID: 30132285
[TBL] [Abstract][Full Text] [Related]
14. The potential markers involved in newly diagnosed graves' disease and the development of active graves' orbitopathy.
He M; Wang Y; Wang J; Sui J; Ding X; Chen Z; Zhang M; Zhao Y; Xie B; Shi B
Cytokine; 2020 Mar; 127():154998. PubMed ID: 31972501
[TBL] [Abstract][Full Text] [Related]
15. Serum Selenium Levels in Patients With Graves Disease With or Without Thyroid Ophthalmopathy.
Owji N; Moradi F; Khalili MR; Jahanbani-Ardakani H
Endocr Pract; 2022 Dec; 28(12):1216-1220. PubMed ID: 36116714
[TBL] [Abstract][Full Text] [Related]
16. Low vitamin D status is associated with hypothyroid Hashimoto's thyroiditis.
Kim D
Hormones (Athens); 2016 Jul; 15(3):385-393. PubMed ID: 27394703
[TBL] [Abstract][Full Text] [Related]
17. Serum prolidase levels in Graves' disease without ophthalmopathy and its association with oxidative status.
Korkmaz H; Tabur S; Ozkaya M; Oguz E; Aksoy N; Akarsu E
J Endocrinol Invest; 2015 Nov; 38(11):1167-73. PubMed ID: 25900177
[TBL] [Abstract][Full Text] [Related]
18. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous measurement of twenty-nine circulating cytokines and growth factors in female patients with overt autoimmune thyroid diseases.
Cheng CW; Wu CZ; Tang KT; Fang WF; Lin JD
Autoimmunity; 2020 Aug; 53(5):261-269. PubMed ID: 32338082
[TBL] [Abstract][Full Text] [Related]
20. Low levels of serum IL-39 are associated with autoimmune thyroid disease.
Weng L; Huang G; Gong L; Xu J; Mao Y; Li Y; Li M
J Clin Lab Anal; 2022 Apr; 36(4):e24284. PubMed ID: 35182078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
